Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-03

Clinical Trial Update: Effect of Probiotic Compound K11T e K11TMax in ASD [NA]

View source ↗

Summary

A completed clinical trial evaluated probiotic compounds K11T and K11TMax for Autism Spectrum Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • K11T
  • K11TMax

Snippet

Sponsor: Deivis de Oliveira guimaraes | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED